KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exact Sciences (EXAS) EBT Margin (2016 - 2025)

Historic EBT Margin for Exact Sciences (EXAS) over the last 17 years, with Q3 2025 value amounting to 2.09%.

  • Exact Sciences' EBT Margin rose 31900.0% to 2.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 32.28%, marking a year-over-year decrease of 244600.0%. This contributed to the annual value of 37.56% for FY2024, which is 294900.0% down from last year.
  • Per Exact Sciences' latest filing, its EBT Margin stood at 2.09% for Q3 2025, which was up 31900.0% from 0.01% recorded in Q2 2025.
  • In the past 5 years, Exact Sciences' EBT Margin registered a high of 0.17% during Q3 2023, and its lowest value of 122.78% during Q4 2024.
  • Moreover, its 5-year median value for EBT Margin was 17.01% (2024), whereas its average is 26.9%.
  • In the last 5 years, Exact Sciences' EBT Margin skyrocketed by 422800bps in 2021 and then crashed by -1150000bps in 2024.
  • Quarter analysis of 5 years shows Exact Sciences' EBT Margin stood at 47.46% in 2021, then soared by 50bps to 23.5% in 2022, then soared by 67bps to 7.79% in 2023, then tumbled by -1477bps to 122.78% in 2024, then skyrocketed by 98bps to 2.09% in 2025.
  • Its last three reported values are 2.09% in Q3 2025, 0.01% for Q2 2025, and 14.29% during Q1 2025.